Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...

Pharmacokinetics in Pediatric Patients: Drug Metabolism

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...

Pharmacokinetics in Pediatric Patients: Drug Excretion

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Aberrant internal carotid artery in the middle ear: two case reports.

B-ENT·2008

Same author

Protection against cisplatin ototoxicity in a Sprague-Dawley rat animal model.

Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale·2008

Same author

Macrophage migration inhibitory factor (MIF) and oligoarticular juvenile idiopathic arthritis (o-JIA): association of MIF promoter polymorphisms with response to intra-articular glucocorticoids.

Clinical and experimental rheumatology·2007

Same author

A longitudinal analysis of physical functional disability over the course of juvenile idiopathic arthritis.

Annals of the rheumatic diseases·2007

Same author

Measuring the psychosocial consequences of hearing loss in a working adult population: focus on validity and reliability of the Italian translation of the hearing handicap inventory.

Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale·2007

Same author

[Brugada syndrome and work place: two case report].

Giornale italiano di medicina del lavoro ed ergonomia·2007

Search research articles

Related Experiment Video

Updated: May 28, 2026

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids

Published on: April 25, 2016

Glucocorticoids in paediatric rheumatology.

A Ravelli¹, B Lattanzi, Al Consolaro

¹Istituto di Ricovero e Cura a Carattere Scientifico G. Gaslini, Italy. angeloravelli@ospedale-gaslini.ge.it

Clinical and Experimental Rheumatology

|October 25, 2011

Summary

Glucocorticoids (GCs) are potent anti-inflammatories for pediatric rheumatic diseases. Judicious use and careful monitoring are crucial due to potential irreversible adverse effects.

Related Experiment Videos

Last Updated: May 28, 2026

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids

Published on: April 25, 2016

Area of Science:

Pediatric Rheumatology
Pharmacology
Immunology

Background:

Glucocorticoids (GCs) are essential for managing pediatric rheumatic diseases like JIA, JLE, JDM, and vasculitis.
GCs are vital for extra-articular manifestations in systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
Current treatment objectives focus on minimizing GC dose and duration to limit toxicity.

Purpose of the Study:

To review the role and optimal use of glucocorticoids in pediatric rheumatic diseases.
To discuss the administration strategies including high-dose intravenous pulse methylprednisolone and intra-articular corticosteroid injections.
To highlight the importance of monitoring GC-associated adverse effects.

Main Methods:

Review of current literature on glucocorticoid use in pediatric rheumatic diseases.
Discussion of therapeutic strategies for systemic and localized inflammation.
Emphasis on dose optimization and toxicity management.

Main Results:

High-dose intravenous pulse methylprednisolone offers rapid anti-inflammatory effects for severe manifestations.
Intra-articular corticosteroid (IAC) injections, particularly triamcinolone hexacetonide, are effective for synovitis in JIA.
GC therapy requires careful dose tapering to maintain disease quiescence while minimizing adverse events.

Conclusions:

Glucocorticoids are potent but carry risks of irreversible adverse effects, necessitating judicious use.
Optimizing GC dosing and considering alternative strategies like IAC injections are key.
Close monitoring for toxicity is essential for safe and effective management of pediatric rheumatic diseases.